Tsai H.-Y.Liao C.-H.ARISTINE CHENGLiu C.-Y.YU-TSUNG HUANGWANG-HUEI SHENGPO-REN HSUEH2021-08-162021-08-1620120163-4453https://www.scopus.com/inward/record.uri?eid=2-s2.0-84869088584&doi=10.1016%2fj.jinf.2012.09.007&partnerID=40&md5=ec4559670e753384ad23bb633c4d3097https://scholars.lib.ntu.edu.tw/handle/123456789/578130[SDGs]SDG3amikacin; ampicillin; carbapenem; cefalexin; cefazolin; cefepime; cefixime; cefmetazole; cefotaxime; creatinine; ertapenem; gentamicin; imipenem; levofloxacin; meropenem; piperacillin plus tazobactam; tigecycline; aged; antibiotic resistance; bacterium isolate; bacteriuria; broth dilution; case report; colony forming unit; creatinine blood level; disk diffusion; dysuria; echography; Escherichia coli infection; female; human; interstitial lung disease; Klebsiella pneumoniae infection; laboratory test; letter; micturition disorder; minimum inhibitory concentration; neutrophil count; polymyositis; pyuria; recurrent infection; urinary tract infection; urine culture; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; MinocyclineEmergence of tigecycline-resistant Klebsiella pneumoniae after tigecycline therapy for complicated urinary tract infection caused by carbapenem-resistant Escherichia colireview10.1016/j.jinf.2012.09.007230002362-s2.0-84869088584